Changes in bone mineral density in patients with Paget's disease treated with alendronate.

被引：0
|
作者：
Nicholson, GC [1 ]
Sanders, KM [1 ]
Kotowicz, MA [1 ]
机构：
[1] Univ Melbourne, Geelong Hosp, Geelong, Vic, Australia
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU440
引用
收藏
页码：S541 / S541
页数：1
相关论文
共 50 条
  • [1] Changes in bone mineral density in patients with Paget's disease treated with risedronate
    Patel, S
    Pearson, D
    Bhallah, A
    Maslanka, W
    White, DA
    Hosking, DJ
    ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (07) : 405 - 409
  • [2] Individual course of trabecular bone density in patients treated with alendronate.
    Neff, M
    Dambacher, MA
    Schönbächler, J
    Radspieler, H
    Qin, L
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S269 - S269
  • [3] Changes in serum cathepsin K levels, CTX and bone mineral density in postmenopausal women treated with alendronate.
    Reyes, R.
    Mezquita-Raya, P.
    Fernandez-Garcia, D.
    Alonso, G.
    Rozas, P.
    Ruiz-Requena, M.
    Luna, J.
    Munoz-Torres, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S183 - S183
  • [4] Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
    Watts, NB
    Jenkins, DK
    Geusens, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S551 - S551
  • [5] Effects of Denosumab vs Alendronate on Bone Mineral Density (BMD), Bone Turnover Markers (BTM), and Safety in Women Previously Treated with Alendronate.
    Kendler, D. L.
    Benhamou, C. L.
    Brown, J. P.
    Lillestol, M.
    Roux, C.
    Man, H. S.
    Siddhanti, S.
    Martin, J. San
    Bone, H. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S473 - S473
  • [6] VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE.
    Catalano, A.
    Bellone, F.
    Gaudio, A.
    Sottile, M. C.
    Stoian, S. A.
    Lo Piano, F.
    Maisano, S.
    Corica, F.
    Morabito, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1745 - 1745
  • [7] Paget's disease on bone mineral density examination
    Tripto-Shkolnik, L.
    Liel, Y.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (01) : 60 - 61
  • [8] Evolution of bone mineral density and bone turnover in osteoporotic women shifting from pamidronate to alendronate.
    Peretz, AME
    Siderova, V
    Body, J
    Dumon, J
    Fellemans, C
    Fuss, M
    Rozenberg, S
    Bergmann, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S527 - S527
  • [9] Exercise improves bone mineral density during treatment of postmenopausal osteoporosis with alendronate.
    Won, Y.
    Kim, H.
    Shin, B.
    Shin, Y.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S295 - S295
  • [10] Alendronate in the treatment of Paget's disease of bone
    Khan, SA
    Vasikaran, S
    McCloskey, EV
    Beneton, MNC
    Rogers, S
    Coulton, L
    Orgee, J
    Coombes, G
    Kanis, JA
    BONE, 1997, 20 (03) : 263 - 271
12345